A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers
Status:
Terminated
Trial end date:
2011-09-20
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to
investigate the safety, tolerability, efficacy and pharmacokinetics (the rate at which the
trial drug is eliminated from the body) of NNC 0070-0002-0453 in overweight/obese, but
otherwise healthy male and female volunteers. Selected subjects will continue in a follow-up
period of up to 5 years.